Active Ingredient(s): Cetuximab
FDA Approved: * February 12, 2004
Pharm Company: * IMCLONE
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Erbitux Overview

Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada by the drug company Eli Lilly and Co. and outside those countries by the drug company Merck KGaA. In Japan, Merck KGaA, Bristol-Myers Squibb...

Read more Erbitux Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Erbitux Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 100mg/50ml
  • Vial: 100mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Erbitux: (4 results)

Sorted by National Drug Code
  • 65044-7462 Erbitux 2 mg/ml Intravenous Solution by Jubilant Hollisterstier LLC
  • 65044-7463 Erbitux 2 mg/ml Intravenous Solution by Jubilant Hollisterstier LLC
  • 66733-948 Erbitux 2 mg/ml Intravenous Solution by Imclone LLC
  • 66733-958 Erbitux 2 mg/ml Intravenous Solution by Imclone LLC

Other drugs which contain Cetuximab or a similar ingredient: (1 result)

Related Erbitux Topics:

I am about to start treatment for a HPV related tonsillar cancer and Erbitux is one of the drugs I will be treated with....

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA